Cetera Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Cetera Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-900	Closed	-$3K	–	1071
2020 Q3	$3K	Sell	900 -1,300	-59%	-$137K	﹤0.01%	951
2020 Q2	$5K	Buy	2,200 +400	+22%	+$31.9K	﹤0.01%	908
2020 Q1	$2K	Buy	+1,800	New	+$126K	﹤0.01%	804
2019 Q3	–	Sell	-2,000	Closed	-$18K	–	968
2019 Q2	$18K	Sell	2,000 -2,200	-52%	-$142K	﹤0.01%	922
2019 Q1	$24K	Buy	+4,200	New	+$221K	﹤0.01%	1058

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Cetera Advisors's TNDM Position: Q2 2022 in Review

Cetera Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,586 shares — an estimated $301K sold.

Cetera Advisors first reported a position in TNDM in Q1 2019 and held it in 9 quarters. The position peaked at $832K in Q2 2019. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Cetera Advisors reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Cetera Advisors sold 2,586 Tandem Diabetes Care shares in Q2 2022, an estimated $301K.
Cetera Advisors first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 9 quarters.
Cetera Advisors's Tandem Diabetes Care position peaked at $832K in Q2 2019.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Cetera Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.